Company Filing History:
Years Active: 2025
Title: Alka Dwivedi: Innovator in Immunotherapy
Introduction
Alka Dwivedi is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development of chimeric antigen receptors.
Latest Patents
Alka Dwivedi holds a patent for her invention titled "Humanized anti-CD19 chimeric antigen receptor, its nucleic acid sequence and its preparation." This invention relates to a novel humanized anti-CD19 chimeric antigen receptor that contains an optimized anti-CD19 binding domain. It is effective in treating diseases associated with the expression of the Cluster of Differentiation 19 protein (CD19). The patent also encompasses a nucleic acid molecule encoding the humanized CAR, a process for its preparation, and compositions containing the CAR, vectors with the polynucleotide encoding the CAR, and cells expressing the CAR on their surface.
Career Highlights
Alka Dwivedi is affiliated with the Indian Institute of Technology Bombay, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and application of immunotherapy techniques.
Collaborations
Alka has collaborated with notable colleagues, including Rahul Purwar and Atharva Karulkar, to further her research initiatives and enhance the impact of her inventions.
Conclusion
Alka Dwivedi's contributions to the field of immunotherapy through her innovative patents highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in medical treatments.